Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-07 Sale |
2025-02-11 09:14 am |
MARINUS PHARMACEUTICALS INC. | MRNS | MAYLEBEN TIMOTHY M Director |
20,857 | $0.55 | $11,471 | 0 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-10-10 Gift |
2024-10-15 07:57 am |
N/A N/A |
MARINUS PHARMACEUTICALS INC. | MRNS | MAYLEBEN TIMOTHY M Director |
6,640 | $0 | 65,631 (Indirect) |
View |
2024-06-18 Option Award |
2024-06-20 4:26 pm |
N/A 2034-06-18 |
MARINUS PHARMACEUTICALS INC. | MRNS | MAYLEBEN TIMOTHY M Director |
12,750 | $0 | 34,825 (Direct) |
View |
2024-01-18 Option Award |
2024-01-19 4:22 pm |
N/A 2034-01-18 |
MARINUS PHARMACEUTICALS INC. | MRNS | MAYLEBEN TIMOTHY M Director |
25,500 | $0 | 42,975 (Direct) |
View |
2023-05-23 Option Award |
2023-05-24 5:57 pm |
N/A 2033-05-22 |
Landos Biopharma Inc. | LABP | MAYLEBEN TIMOTHY M Director |
18,000 | $0 | 18,000 (Direct) |
View |
2023-01-26 Option Award |
2023-01-30 4:22 pm |
N/A 2033-01-26 |
MARINUS PHARMACEUTICALS INC. | MRNS | MAYLEBEN TIMOTHY M Director |
19,800 | $0 | 33,675 (Direct) |
View |
2022-06-17 Option Award |
2022-06-22 4:29 pm |
N/A 2032-06-16 |
Landos Biopharma Inc. | LABP | MAYLEBEN TIMOTHY M Director |
18,000 | $0 | 18,000 (Direct) |
View |
2022-02-04 Option Award |
2022-02-07 4:12 pm |
N/A 2032-02-04 |
MARINUS PHARMACEUTICALS INC | MRNS | MAYLEBEN TIMOTHY M Director |
15,125 | $0 | 26,250 (Direct) |
View |
2021-12-17 Option Award |
2021-12-21 4:21 pm |
N/A 2031-12-16 |
Landos Biopharma Inc. | LABP | MAYLEBEN TIMOTHY M Interim CEO |
253,485 | $0 | 253,485 (Direct) |
View |
2021-05-13 Option Award |
2021-05-17 5:57 pm |
N/A 2031-05-12 |
Landos Biopharma Inc. | LABP | MAYLEBEN TIMOTHY M Director |
36,000 | $0 | 36,000 (Direct) |
View |
2021-01-28 Option Award |
2021-01-29 5:01 pm |
N/A 2031-01-28 |
Esperion Therapeutics Inc. | ESPR | MAYLEBEN TIMOTHY M President & CEO |
175,000 | $0 | 175,000 (Direct) |
View |
2021-01-15 Option Award |
2021-01-19 8:10 pm |
N/A 2031-01-15 |
MARINUS PHARMACEUTICALS INC | MRNS | MAYLEBEN TIMOTHY M Director |
16,500 | $0 | 16,500 (Direct) |
View |
2020-12-30 Exercise |
2020-12-31 4:09 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | MAYLEBEN TIMOTHY M President & CEO |
10,700 | $2.096 | 385,657 (Direct) |
View |
2020-12-30 Exercise |
2020-12-31 4:09 pm |
N/A 2023-01-16 |
Esperion Therapeutics Inc. | ESPR | MAYLEBEN TIMOTHY M President & CEO |
10,700 | $0 | 385,657 (Direct) |
View |